BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8337438)

  • 41. Adrenal tissue characterization using MR imaging.
    Glazer GM; Woolsey EJ; Borrello J; Francis IR; Aisen AM; Bookstein F; Amendola MA; Gross MD; Bree RL; Martel W
    Radiology; 1986 Jan; 158(1):73-9. PubMed ID: 3940402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Magnetic resonance imaging of functioning paragangliomas.
    Falke TH; van Gils AP; van Seters AP; Sandler MP
    Magn Reson Q; 1990 Jan; 6(1):35-64. PubMed ID: 2166554
    [No Abstract]   [Full Text] [Related]  

  • 43. [MRI of pheochromocytoma].
    Ishii K; Yoshida Y; Matsui R; Shimizu M; Kono M; Harada Y; Tanaka Y; Ushio K
    Rinsho Hoshasen; 1990 Sep; 35(9):1021-6. PubMed ID: 2232276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Experimental study of differentiation between tumor and inflammation using MR imaging: correlation between VX2 tumors and croton oil induced inflammation in the rabbit's femoral muscle].
    Saginoya T; Yamaguchi K; Nakano M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jun; 54(7):592-604. PubMed ID: 8065881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. State-of-the-art MR imaging of the adrenal gland.
    Lee MJ; Mayo-Smith WW; Hahn PF; Goldberg MA; Boland GW; Saini S; Papanicolaou N
    Radiographics; 1994 Sep; 14(5):1015-29; discussion 1029-32. PubMed ID: 7991811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benign adrenal lesions mimicking malignancy on MR imaging: report of two cases.
    Baker ME; Spritzer C; Blinder R; Herfkens RJ; Leight GS; Dunnick NR
    Radiology; 1987 Jun; 163(3):669-71. PubMed ID: 3575711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MRI of the breast--histopathologic correlation.
    Heywang SH; Bassermann R; Fenzl G; Nathrath W; Hahn D; Beck R; Krischke I; Eiermann W
    Eur J Radiol; 1987 Aug; 7(3):175-82. PubMed ID: 3653109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant parotid tumors: clinical use of MR imaging and histologic correlation.
    Freling NJ; Molenaar WM; Vermey A; Mooyaart EL; Panders AK; Annyas AA; Thijn CJ
    Radiology; 1992 Dec; 185(3):691-6. PubMed ID: 1438746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinicomorphological aspects of adrenal pheochromocytoma diagnostics].
    Khmel'nitskaia NM; Il'inskaia EV; Filippova OV
    Arkh Patol; 2011; 73(5):36-40. PubMed ID: 22288171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MR imaging of extraabdominal desmoids: differentiation from other neoplasms.
    Hartman TE; Berquist TH; Fetsch JF
    AJR Am J Roentgenol; 1992 Mar; 158(3):581-5. PubMed ID: 1738999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MR differentiation of phaeochromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times.
    Varghese JC; Hahn PF; Papanicolaou N; Mayo-Smith WW; Gaa JA; Lee MJ
    Clin Radiol; 1997 Aug; 52(8):603-6. PubMed ID: 9285420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The diagnosis of tumors of the chromaffin tissue by magnetic resonance tomography].
    Pustovitova TS; Belichenko OI
    Ter Arkh; 1989; 61(12):77-80. PubMed ID: 2629152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pheochromocytoma: an imaging chameleon.
    Blake MA; Kalra MK; Maher MM; Sahani DV; Sweeney AT; Mueller PR; Hahn PF; Boland GW
    Radiographics; 2004 Oct; 24 Suppl 1():S87-99. PubMed ID: 15486252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Remarkably suppressed manganese superoxide dismutase activity in malignant pheochromocytoma.
    Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
    J Urol; 1995 Jun; 153(6):1787-90. PubMed ID: 7752317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MR imaging of chest wall lesions.
    Fortier M; Mayo JR; Swensen SJ; Munk PL; Vellet DA; Müller NL
    Radiographics; 1994 May; 14(3):597-606. PubMed ID: 8066274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MR signal intensity of parathyroid adenomas: correlation with histopathology.
    Auffermann W; Guis M; Tavares NJ; Clark OH; Higgins CB
    AJR Am J Roentgenol; 1989 Oct; 153(4):873-6. PubMed ID: 2773745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative Analysis of FSE T2 Weighted, Chemical Shift and Dynamic Contrast-Enhanced MR Imaging in the Characterization of Adrenal Masses Based on Qualitative and Quantitative Parameters.
    Halefoglu AM; Bodelschwingh BV; Altuntas Y; Memis B
    Sisli Etfal Hastan Tip Bul; 2024; 58(1):30-44. PubMed ID: 38808044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences.
    Outwater EK; Siegelman ES; Huang AB; Birnbaum BA
    Radiology; 1996 Sep; 200(3):749-52. PubMed ID: 8756926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Magnetic resonance tomographic diagnosis of a myelolipoma of the adrenal glands].
    Gaa J; Saini S; Mueller PR; Ferrucci JT
    Radiologe; 1991 Feb; 31(2):86-8. PubMed ID: 2034817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [MR-tomographic diagnosis of pheochromocytoma].
    Pustovitova TS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):114-5. PubMed ID: 3426809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.